Sangwhan In

Sangwhan In

Auto-generated profile, based on publicly available information

Sangwhan In

Forensic Toxicology Division, Daegu Institute, National Forensic Service, Andong-si 39872, Gyeongsangbuk-do, Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Forensic Science International
Verified
Journal Article
Closed access
HCHan Soo Cho
Han Soo Cho
BCByungseok Cho
Byungseok Cho
JSJuhyun Sim
Juhyun Sim
SBSeung Kyung Baeck
Seung Kyung Baeck
SISangwhan In
Sangwhan In
EKEunmi Kim
Eunmi Kim

16 July 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
HLHo-Sun Lee
Ho-Sun Lee
SISanghwan In
Sanghwan In
Taesung ParkTaesung Park
Taesung Park
Homocysteine (Hcy) is well known to be increased in the metabolic syndrome (MetS) incidence. However, it remains unclear whether the relationship is causal or not. Recently, Mendelian Randomization (MR) has been popularly used to assess the causal influence. In this study, we adopted MR to investigate the causal influence of Hcy on MetS in adults using three independent cohorts. We considered one-sample MR and two-sample MR. We analyzed one-sample MR in 5902 individuals (2090 MetS cases and 3812 controls) from the KARE and two-sample MR from the HEXA (676 cases and 3017 controls) and CAVAS (1052 cases and 764 controls) datasets to evaluate whether genetically increased Hcy level influences the risk of MetS. In observation studies, the odds of MetS increased with higher Hcy concentrations (odds ratio (OR) 1.17, 95%CI 1.12–1.22, p < 0.01). One-sample MR was performed using two-stage least-squares regression, with an MTHFR C677T and weighted Hcy generic risk score as an instrument. Two-sample MR was performed with five genetic variants (rs12567136, rs1801133, rs2336377, rs1624230, and rs1836883) by GWAS data as the instrumental variables. For sensitivity analysis, weighted median and MR–Egger regression were used. Using one-sample MR, we found an increased risk of MetS (OR 2.07 per 1-SD Hcy increase). Two-sample MR supported that increased Hcy was significantly associated with increased MetS risk by using the inverse variance weighted (IVW) method (beta 0.723, SE 0.119, and p < 0.001), the weighted median regression method (beta 0.734, SE 0.097, and p < 0.001), and the MR–Egger method (beta 2.073, SE 0.843, and p = 0.014) in meta-analysis. The MR–Egger slope showed no evidence of pleiotropic effects (intercept −0.097, p = 0.107). In conclusion, this study represented the MR approach and elucidates the significant relationship between Hcy and the risk of MetS in the Korean population.


1 June 2017 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
JSJuhyun Sim
Juhyun Sim
HCHan Soo Cho
Han Soo Cho
JLJaesin Lee
Jaesin Lee
SISangwhan In
Sangwhan In
EKEunmi Kim
Eunmi Kim

25 February 2019 in Molecules
Verified
Journal Article
Open access
PDF file
JKJu-Hyun Kim
Ju-Hyun Kim
SKsunjoo kim
sunjoo kim
JLJaesin Lee
Jaesin Lee
SISangwhan In
Sangwhan In
Yong-Yeon ChoYong-Yeon Cho
Yong-Yeon Cho
Hye Suk LeeHye Suk Lee
Hye Suk Lee
25B-NBF, 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine, is a new psychoactive substance classified as a phenethylamine. It is a potent agonist of the 5-hydroxytryptamine receptor, but little is known about its metabolism and elimination properties since it was discovered. To aid 25B-NBF abuse screening, the metabolic characteristics of 25B-NBF were investigated in human hepatocytes and human cDNA-expressed cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes using liquid chromatography–high resolution mass spectrometry. At a hepatic extraction ratio of 0.80, 25B-NBF was extensively metabolized into 33 metabolites via hydroxylation, O-demethylation, bis-O-demethylation, N-debenzylation, glucuronidation, sulfation, and acetylation after incubation with pooled human hepatocytes. The metabolism of 25B-NBF was catalyzed by CYP1A1, CYP1A2, CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP2J2, CYP3A4, and UGT2B7 enzymes. Based on these results, it is necessary to develop a bioanalytical method for the determination of not only 25B-NBF but also its metabolites in biological samples for the screening of 25B-NBF abuse.